Overview
AdvanSix Q3 sales of $374 mln, down 6% yr/yr amid challenging market conditions
Adjusted EPS for Q3 at $0.08, reflecting lower pricing in Chemical Intermediates
Company cites ongoing benefits from SUSTAIN growth program and strong Plant Nutrients
Outlook
AdvanSix expects 2025 capital expenditures to be $120-$125 mln, reflecting $30 mln cash conservation
Company anticipates continued strength in Plant Nutrients amid higher raw material costs
AdvanSix expects cash flow tailwind in 2026 from carbon capture tax credits and bonus depreciation
Result Drivers
PLANT NUTRIENTS - Strong performance in Plant Nutrients driven by favorable supply and demand conditions in North America
RAW MATERIAL COSTS - Higher raw material input costs impacted pricing strategy, particularly in Chemical Intermediates
PRODUCTION ADJUSTMENTS - Co moderated production rates to manage inventory levels amid weak market conditions in Nylon Solutions
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Sales | $374.47 mln | ||
Q3 Adjusted EPS | $0.08 | ||
Q3 Net Income | -$2.64 mln | ||
Q3 Adjusted EBITDA | $24.73 mln | ||
Q3 Adjusted EBITDA Margin | 6.60% | ||
Q3 Free Cash Flow | $66,000 |
Analyst Coverage
The one available analyst rating on the shares is "buy"
The average consensus recommendation for the specialty chemicals peer group is "buy"
Wall Street's median 12-month price target for AdvanSix Inc is $28.00, about 35.2% above its November 6 closing price of $18.15
Press Release: ID:nBw6hpNtka
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)